SARS_CoV_2 Infection Clinical Trials in Omaha

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • SARS-CoV-2 Infection
  • Intramuscular injection
  • Intramuscular vaccine
  • Birmingham, Alabama
  • +90 more
2022-04-04
Apr 4, 2022
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +152 more
2022-03-29
Mar 29, 2022
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2022-03-25
Mar 25, 2022
P
Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
2022-03-23
Mar 23, 2022
V
Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +64 more
2022-03-07
Mar 7, 2022
B
Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
2022-02-17
Feb 17, 2022
N
Not yet recruiting
  • SARS-CoV-2 Infection
    • Birmingham, Alabama
    • +71 more
    2022-02-03
    Feb 3, 2022
    O
    Completed
    • Covid19
    • +2 more
    • Rayaldee 30Mcg Extended-Release (ER) Capsule
    • Placebo
    • San Francisco, California
    • +9 more
    2021-10-14
    Oct 14, 2021
    N
    Recruiting
    • SARS-CoV-2 Infection
    • Moderna COVID-19 Vaccine
    • Birmingham, Alabama
    • +54 more
    2021-08-06
    Aug 6, 2021